BEAM NASDAQ
Beam Therapeutics Inc.
1W: +0.9%
1M: -16.4%
3M: -30.6%
YTD: -9.7%
1Y: +1.5%
3Y: +1.0%
5Y: -74.1%
$24.50
+0.11 (+0.45%)
Weekly Expected Move ±7.9%
$21
$23
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$156M
Revenue
+158.9% YoY
$-85M
Net Income
+78.6% YoY
$-373M
Free Cash Flow
-4.8% YoY
100.0%
Gross Margin
-25827.1%
Op. Margin
-25036.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-8.1%
ROA-6.2%
ROIC-184.5%
Valuation
P/E-29.9
P/B2.4
EV/EBITDA-44.4
Leverage
Debt/Equity0.23
Current Ratio14.57
Interest Cov.-7.8x
Quality Scores
Piotroski F4/9
Altman Z5.72
Beneish M-11.70